M42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP)
Explore MoreM42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
Explore MoreLaunch groundbreaking effort to advance precision medicine by delivering pharmacogenomic insight at the point of care
Explore MoreM42 formalizes its 12-year presence in the Kingdom at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare
Explore MoreIn a landmark step for the region’s biomedical innovation ecosystem, Abu Dhabi Biobank, a strategic initiative between the Depar...
In a major step towards advancing biomedical research and innovative therapies, Abu Dhabi Biobank and Mediclinic Middle East hav...
M42, a global health leader powered by artificial intelligence (AI), technology and genomics, today announced the official inaug...
In an exciting opportunity for next-gen drug development, IROS, an Abu Dhabi-based contract research organization and part of th...
18 community, corporate, and government engagements delivered across Abu Dhabi, Al Ain, and Al Dhafra
M42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministr...
